Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Sparsentan Shows Clinically Meaningful Treatment Effects vs Irbesartan in Patients With IgA Nephropathy (IgAN) in the Phase 3 PROTECT Trial

Page 1 / 1 100%
Loading...